Denver Investment Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Denver Investment Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-16,340	Closed	-$230K	–	446
2017 Q3	$230K	Hold	16,340	–	–	0.01%	410
2017 Q2	$122K	Hold	16,340	–	–	0.01%	433
2017 Q1	$106K	Buy	+16,340	New	+$91.4K	﹤0.01%	445
2016 Q4	–	Sell	-15,661	Closed	-$73K	–	511
2016 Q3	$73K	Sell	15,661 -1,124	-7%	-$6.66K	﹤0.01%	432
2016 Q2	$110K	Sell	16,785 -3,519	-17%	-$24.9K	0.01%	424
2016 Q1	$129K	Sell	20,304 -13,092	-39%	-$67.2K	0.01%	419
2015 Q4	$201K	Sell	33,396 -3,792	-10%	-$21.7K	0.01%	446
2015 Q3	$222K	Sell	37,188 -1,280	-3%	-$8.89K	0.01%	443
2015 Q2	$263K	Sell	38,468 -10,505	-21%	-$66.7K	0.01%	439
2015 Q1	$297K	Buy	48,973 +21,195	+76%	+$141K	0.01%	481
2014 Q4	$193K	Buy	27,778 +116	+0.4%	+$853	0.01%	573
2014 Q3	$225K	Buy	27,662 +1,562	+6%	+$12.2K	0.01%	507
2014 Q2	$212K	Hold	26,100	–	–	0.01%	536
2014 Q1	$205K	Buy	26,100 +13,409	+106%	+$113K	0.01%	553
2013 Q4	$112	Hold	12,691	–	–	﹤0.01%	543
2013 Q3	$106K	Buy	+12,691	New	+$103K	﹤0.01%	558

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Denver Investment Advisors's SPPI Position: Q4 2017 in Review

Denver Investment Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2017, closing a stake of 16,340 shares — an estimated $230K sold.

Denver Investment Advisors first reported a position in SPPI in Q3 2013 and held it in 16 quarters. The position peaked at $297K in Q1 2015. 157 funds tracked by Wall St. Rank hold SPPI as of Q4 2017.

Denver Investment Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Denver Investment Advisors sold 16,340 Spectrum Pharmaceuticals Inc shares in Q4 2017, an estimated $230K.
Denver Investment Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q3 2013 and held it in 16 quarters.
Denver Investment Advisors's Spectrum Pharmaceuticals Inc position peaked at $297K in Q1 2015.
157 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2017.

Based on Denver Investment Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.